2013 Fiscal Year Final Research Report
Development of a novel vaccine carrier for the next-generation influenza universal vaccine
Project/Area Number |
23590550
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Virology
|
Research Institution | Saitama Medical University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
KAWANO Masaaki 埼玉医科大学, 医学部, 助教 (30447528)
|
Co-Investigator(Renkei-kenkyūsha) |
HANDA Hiroshi 東京医科大学, 医学部, 特任教授 (80107432)
|
Project Period (FY) |
2011 – 2013
|
Keywords | ワクチン / 感染防御 / ウイルス様粒子 / SV40 / ナノキャリア / 細胞傷害性T細胞 / HLA class I / インフルエンザウイルス |
Research Abstract |
Virus-like particles (VLPs) are a promising vaccine platform due to the safety and efficiency. However, it is still unclear whether polyomavirus-based VLPs are useful for this purpose. Here, we attempted to evaluate the potential of polyomavirus VLPs for the antiviral vaccine using simian virus 40 (SV40). We constructed chimeric SV40-VLPs carrying an HLA-A*02:01-restricted, cytotoxic T lymphocyte (CTL) epitope derived from influenza A virus. HLA-A*02:01-transgenic mice were then immunized with the chimeric SV40-VLPs. The chimeric SV40-VLPs effectively induced influenza-specific CTLs and heterosubtypic protection against influenza A viruses without the need of adjuvants. In addition, immunization with the chimeric SV40-VLPs generated long-lasting memory CTLs. We here propose that the chimeric SV40-VLPs harboring an epitope may be a promising CTL-based vaccine platform with self-adjuvant properties.
|
Research Products
(12 results)
-
-
-
[Journal Article] Viral protein-coating of magnetic nanoparticles using simian virus 40 VP12013
Author(s)
Enomoto, T., M. Kawano, H. Fukuda, W. Sawada, T. Inoue, K. C. Haw, Y. Kita, S. Sakamoto, Y. Yamaguchi, T. Imai, M. Hatakeyama, S. Saito, A. Sandhu, M. Matsui, I. Aoki, and H. Handa
-
Journal Title
J. Biotechnol
Volume: 167(1)
Pages: 8-15
DOI
Peer Reviewed
-
-
-
-
-
-
-
-
-